# Janux Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 16:16 ET
- Period: 2024-06-26
- Accession: 0000950170-24-049873
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000095017024049873/janx_def_14a_2024_non_xb.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000095017024049873/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000095017024049873/janx_def_14a_2024_non_xb.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-049873. Last ingested by Listed: Nov 5, 2026, 18:20 ET. No prices; not investment advice.